GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Titan Medical Inc (FRA:QTNA) » Definitions » EV-to-EBIT

Titan Medical (FRA:QTNA) EV-to-EBIT : 0.01 (As of May. 27, 2024)


View and export this data going back to . Start your Free Trial

What is Titan Medical EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Titan Medical's Enterprise Value is €0.07 Mil. Titan Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €8.26 Mil. Therefore, Titan Medical's EV-to-EBIT for today is 0.01.

The historical rank and industry rank for Titan Medical's EV-to-EBIT or its related term are showing as below:

FRA:QTNA' s EV-to-EBIT Range Over the Past 10 Years
Min: -9.79   Med: -1.85   Max: 23.07
Current: 0.01

During the past 13 years, the highest EV-to-EBIT of Titan Medical was 23.07. The lowest was -9.79. And the median was -1.85.

FRA:QTNA's EV-to-EBIT is ranked better than
98.89% of 452 companies
in the Medical Devices & Instruments industry
Industry Median: 20.2 vs FRA:QTNA: 0.01

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Titan Medical's Enterprise Value for the quarter that ended in Mar. 2024 was €0.94 Mil. Titan Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €8.26 Mil. Titan Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 878.50%.


Titan Medical EV-to-EBIT Historical Data

The historical data trend for Titan Medical's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Titan Medical EV-to-EBIT Chart

Titan Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.46 -5.12 -2.75 -1.71 0.08

Titan Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.44 -0.37 -2.60 0.08 0.21

Competitive Comparison of Titan Medical's EV-to-EBIT

For the Medical Devices subindustry, Titan Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Titan Medical's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Titan Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Titan Medical's EV-to-EBIT falls into.



Titan Medical EV-to-EBIT Calculation

Titan Medical's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.067/8.256
=0.01

Titan Medical's current Enterprise Value is €0.07 Mil.
Titan Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €8.26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Titan Medical  (FRA:QTNA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Titan Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=8.256/0.93978
=878.50 %

Titan Medical's Enterprise Value for the quarter that ended in Mar. 2024 was €0.94 Mil.
Titan Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €8.26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Titan Medical EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Titan Medical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Titan Medical (FRA:QTNA) Business Description

Traded in Other Exchanges
Address
76 Berkeley Street, Toronto, ON, CAN, M5A 2W7
Titan Medical Inc is in the research and development stage and is focused on the continued design and development of robotic-assisted surgical technologies for application in minimally invasive surgery including the development of the Enos robotic single-access surgical system.

Titan Medical (FRA:QTNA) Headlines

From GuruFocus

Quantenna to Release Third Quarter Financial Results on October 29, 2018

By GlobeNewswire GlobeNewswire 10-15-2018

Quantenna to Present at Upcoming Investor Conferences

By Marketwired Marketwired 02-12-2019